Literature DB >> 2481268

Increased Sp1 binding mediates erythroid-specific overexpression of a mutated (HPFH) gamma-globulin promoter.

A Ronchi1, S Nicolis, C Santoro, S Ottolenghi.   

Abstract

The -198 T----C mutation in the promoter of the A gamma-globin gene increases 20-30 fold the expression of this gene in adult erythroid cells of patients (Hereditary Persistence of Fetal Hemoglobin, HPFH). We show here that this mutation creates a strong binding site, resembling a CACCC box, for two ubiquitous nuclear proteins, one of which is Sp1. The mutated promoter is four to five-fold more efficient than a normal gamma-globin promoter in driving expression of a CAT reporter plasmid when transfected into erythroid cells. The overexpression of the mutant is abolished by the introduction of an additional mutation disrupting the new binding site. No overexpression of the mutant is observed in non-erythroid cells, indicating that the ubiquitous factors bound on the mutated sequence must cooperate with erythroid specific factors.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2481268      PMCID: PMC335297          DOI: 10.1093/nar/17.24.10231

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  28 in total

1.  The British form of hereditary persistence of fetal hemoglobin results from a single base mutation adjacent to an S1 hypersensitive site 5' to the A gamma globin gene.

Authors:  V E Tate; W G Wood; D J Weatherall
Journal:  Blood       Date:  1986-12       Impact factor: 22.113

2.  Chinese A gamma fetal hemoglobin: C to T substitution at position-196 of the A gamma gene promoter.

Authors:  R Gelinas; M Bender; C Lotshaw; P Waber; H Kazazian; G Stamatoyannopoulos
Journal:  Blood       Date:  1986-06       Impact factor: 22.113

3.  The same nuclear proteins bind the proximal CACCC box of the human beta-globin promoter and a similar sequence in the enhancer.

Authors:  B Giglioni; P Comi; A Ronchi; R Mantovani; S Ottolenghi
Journal:  Biochem Biophys Res Commun       Date:  1989-10-16       Impact factor: 3.575

4.  A nuclear factor that binds to a conserved sequence motif in transcriptional control elements of immunoglobulin genes.

Authors:  H Singh; R Sen; D Baltimore; P A Sharp
Journal:  Nature       Date:  1986 Jan 9-15       Impact factor: 49.962

5.  Properties of a CCAAT box-binding protein.

Authors:  R A Hooft van Huijsduijnen; J Bollekens; A Dorn; C Benoist; D Mathis
Journal:  Nucleic Acids Res       Date:  1987-09-25       Impact factor: 16.971

6.  Purification and biochemical characterization of the promoter-specific transcription factor, Sp1.

Authors:  M R Briggs; J T Kadonaga; S P Bell; R Tjian
Journal:  Science       Date:  1986-10-03       Impact factor: 47.728

7.  G gamma beta+ hereditary persistence of fetal hemoglobin: cosmid cloning and identification of a specific mutation 5' to the G gamma gene.

Authors:  F S Collins; C J Stoeckert; G R Serjeant; B G Forget; S M Weissman
Journal:  Proc Natl Acad Sci U S A       Date:  1984-08       Impact factor: 11.205

8.  Activation of the AIDS retrovirus promoter by the cellular transcription factor, Sp1.

Authors:  K A Jones; J T Kadonaga; P A Luciw; R Tjian
Journal:  Science       Date:  1986-05-09       Impact factor: 47.728

9.  Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei.

Authors:  J D Dignam; R M Lebovitz; R G Roeder
Journal:  Nucleic Acids Res       Date:  1983-03-11       Impact factor: 16.971

10.  A molecular study of a family with Greek hereditary persistence of fetal hemoglobin and beta-thalassemia.

Authors:  B Giglioni; C Casini; R Mantovani; S Merli; P Comi; S Ottolenghi; G Saglio; C Camaschella; U Mazza
Journal:  EMBO J       Date:  1984-11       Impact factor: 11.598

View more
  14 in total

1.  Synergistic activation of a human promoter in vivo by transcription factor Sp1.

Authors:  G M Anderson; S O Freytag
Journal:  Mol Cell Biol       Date:  1991-04       Impact factor: 4.272

2.  Purification and identification of proteins that bind to the hereditary persistence of fetal hemoglobin -198 mutation in the gamma-globin gene promoter.

Authors:  Ivan A Olave; Catalin Doneanu; Xiangdong Fang; George Stamatoyannopoulos; Qiliang Li
Journal:  J Biol Chem       Date:  2006-11-17       Impact factor: 5.157

3.  Functional profile of the human fetal gamma-globin gene upstream promoter region.

Authors:  H J Lin; C Y Han; A W Nienhuis
Journal:  Am J Hum Genet       Date:  1992-08       Impact factor: 11.025

4.  Methylation-enhanced binding of Sp1 to the stage selector element of the human gamma-globin gene promoter may regulate development specificity of expression.

Authors:  S M Jane; D L Gumucio; P A Ney; J M Cunningham; A W Nienhuis
Journal:  Mol Cell Biol       Date:  1993-06       Impact factor: 4.272

5.  Exhaustive mutation scanning by fluorescence-assisted mismatch analysis discloses new genotype-phenotype correlations in angiodema.

Authors:  E Verpy; M Biasotto; M Brai; G Misiano; T Meo; M Tosi
Journal:  Am J Hum Genet       Date:  1996-08       Impact factor: 11.025

6.  Analysis of the mechanism of action of non-deletion hereditary persistence of fetal hemoglobin mutants in transgenic mice.

Authors:  Q Li; Z J Duan; G Stamatoyannopoulos
Journal:  EMBO J       Date:  2001-01-15       Impact factor: 11.598

7.  The T----C substitution at -198 of the A gamma-globin gene associated with the British form of HPFH generates overlapping recognition sites for two DNA-binding proteins.

Authors:  K D Fischer; J Nowock
Journal:  Nucleic Acids Res       Date:  1990-10-11       Impact factor: 16.971

8.  An erythroid specific enhancer upstream to the gene encoding the cell-type specific transcription factor GATA-1.

Authors:  S Nicolis; C Bertini; A Ronchi; S Crotta; L Lanfranco; E Moroni; B Giglioni; S Ottolenghi
Journal:  Nucleic Acids Res       Date:  1991-10-11       Impact factor: 16.971

9.  Hemoglobin switching in humans is accompanied by changes in the ratio of the transcription factors, GATA-1 and SP1.

Authors:  E R Bacon; N Dalyot; D Filon; L Schreiber; E A Rachmilewitz; A Oppenheim
Journal:  Mol Med       Date:  1995-03       Impact factor: 6.354

10.  A single-base substitution in the proximal Sp1 site of the human low density lipoprotein receptor promoter as a cause of heterozygous familial hypercholesterolemia.

Authors:  U M Koivisto; J J Palvimo; O A Jänne; K Kontula
Journal:  Proc Natl Acad Sci U S A       Date:  1994-10-25       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.